Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Haines

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular and Cellular Biology|March 11, 2009
Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiationEric Haines, Parham Minoo, Zhenqian Feng, et al.
Journal for Immunotherapy of Cancer|November 2, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonismKristen Hurov, Johanna Lahdenranta, Punit Upadhyaya, et al.
Nature Cancer|January 2, 2026
The MEK-RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancersEric Haines, Michael Burke, Rachel Catterall, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonistPunit Upadhyaya, Johanna Lahdenranta, Kristen Hurov, et al.
Molecular Cancer Therapeutics|September 16, 2022
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid TumorsMichael Rigby, Gavin Bennett, Liuhong Chen, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular and Cellular Biology|March 11, 2009
Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiationEric Haines, Parham Minoo, Zhenqian Feng, et al.
Journal for Immunotherapy of Cancer|November 2, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonismKristen Hurov, Johanna Lahdenranta, Punit Upadhyaya, et al.
Nature Cancer|January 2, 2026
The MEK-RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancersEric Haines, Michael Burke, Rachel Catterall, et al.
Journal for Immunotherapy of Cancer|January 27, 2021
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonistPunit Upadhyaya, Johanna Lahdenranta, Kristen Hurov, et al.
Molecular Cancer Therapeutics|September 16, 2022
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid TumorsMichael Rigby, Gavin Bennett, Liuhong Chen, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Pageof 2